Evidence map›Paper›PMID 41787953›Full record

ArticleEnvironmental science & technology2026

Is There an Optimal Wavelength for Germicidal Ultraviolet Air Disinfection?

Zhe Peng, Ben Ma, Daven K Henze, Shelly L Miller, Joost A de Gouw, Jose L Jimenez

Abstract read
In one paragraph

Article in Environmental science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhe PengCollege of Environment and Climate, Guangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality, Jinan University, Guangzhou, Guangdong 511443, China.ORCID 0000-0002-6823-452X
Ben MaDepartment of Civil and Environmental Engineering, University of Nevada, Reno, Nevada 89557, United States.ORCID 0000-0002-6635-7622
Daven K HenzePaul M. Rady Department of Mechanical Engineering, University of Colorado, Boulder, Colorado 80309, United States.
Shelly L MillerPaul M. Rady Department of Mechanical Engineering, University of Colorado, Boulder, Colorado 80309, United States.ORCID 0000-0002-1967-7551
Joost A de GouwDepartment of Chemistry and Cooperative Institute for Research in Environmental Sciences (CIRES), University of Colorado, Boulder, Colorado 80309, United States.ORCID 0000-0002-0385-1826
Jose L JimenezDepartment of Chemistry and Cooperative Institute for Research in Environmental Sciences (CIRES), University of Colorado, Boulder, Colorado 80309, United States.ORCID 0000-0001-6203-1847

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Germicidal UV (GUV) disinfection is effective against airborne pathogens, but it has been recently reported to increase indoor air pollution. Conventional GUV at 254 nm is applied in the upper room only due to skin/eye safety limits, while "Far UVC" (e.g., at 222 nm) is applied across the whole room due to less restrictive safety limits, enabling simpler installation and disinfection. GUV light sources at other wavelengths are being actively developed, creating an urgent need for guidance on their relative advantages. We investigate GUV between 185 and 310 nm by modeling in search of an optimal wavelength with both high disinfection and safety. For a specific fluence rate, GUV-induced air pollution health risks are at least ∼20 times larger below 242 nm than above it. This is mainly due to O

Indexed as

DisinfectionUltraviolet RaysAir Pollution, Indoorair disinfectionatmospheric chemical modelinggermicidal ultraviolethealth effectsindoor air quality

Identifiers

PMID41787953
PMCPMC13085799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.